These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21650014)

  • 1. [Determination of nabumetone and 6-methoxy-2-naphthylacetic acid in plasma using HPLC with UV and MS detection].
    Nespesná L; Stícha M; Matousková O; Perlík F; Slanar O
    Ceska Slov Farm; 2011 Feb; 60(1):17-24. PubMed ID: 21650014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extractionless determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by high-performance liquid chromatography.
    de Jager AD; Hundt HK; Hundt AF; Swart KJ; Knight M; Roberts J
    J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):247-51. PubMed ID: 10821411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by HPLC].
    Qin Y; Zou Y; Liang M; Huang Y; Yu Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):452-4. PubMed ID: 11387968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput LC-MS/MS assay for 6-methoxy-2-naphthylacetic acid, an active metabolite of nabumetone in human plasma and its application to bioequivalence study.
    Patel BN; Sharma N; Sanyal M; Prasad A; Shrivastav PS
    Biomed Chromatogr; 2008 Nov; 22(11):1213-24. PubMed ID: 18651608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.
    Nobilis M; Mikušek J; Szotáková B; Jirásko R; Holčapek M; Chamseddin C; Jira T; Kučera R; Kuneš J; Pour M
    J Pharm Biomed Anal; 2013 Jun; 80():164-72. PubMed ID: 23584048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous analysis of naproxen, nabumetone and its major metabolite 6-methoxy-2-naphthylacetic acid in pharmaceuticals and human urine by high-performance liquid chromatography.
    Mikami E; Goto T; Ohno T; Matsumoto H; Nishida M
    J Pharm Biomed Anal; 2000 Oct; 23(5):917-25. PubMed ID: 11022916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative biotransformation and disposition studies of nabumetone in humans and minipigs using high-performance liquid chromatography with ultraviolet, fluorescence and mass spectrometric detection.
    Nobilis M; Kopecký J; Kvetina J; Svoboda Z; Pour M; Kunes J; Holcapek M; Kolárová L
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):641-56. PubMed ID: 12899954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
    Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
    Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabumetone and 6-MNA Pharmacokinetics, Assessment of Intrasubject Variability and Gender Effect.
    Světlík S; Štícha M; Matoušková O; Nespěšná L; Sklenář Z; Bartůněk A; Perlík F; Slanař O
    Am J Ther; 2016; 23(6):e1498-e1503. PubMed ID: 25393072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic study of the active metabolite of nabumetone in young healthy subjects and older arthritis patients.
    Kendall MJ; Chellingsworth MC; Jubb R; Thawley AR; Undre NA; Kill DC
    Eur J Clin Pharmacol; 1989; 36(3):299-305. PubMed ID: 2744071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of the active metabolite of nabumetone into synovial fluid and adherent tissue of patients undergoing knee joint surgery.
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Giersch KH; Münzel P
    Drugs; 1990; 40 Suppl 5():57-61. PubMed ID: 2081495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.
    Matsumoto K; Hasegawa T; Ohara K; Takei C; Kamei T; Koyanagi J; Takahashi T; Akimoto M
    Xenobiotica; 2020 Jul; 50(7):783-792. PubMed ID: 31855101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of LC/MS/MS assay for 6-methoxy-2-napthylacetic acid to support the bioequivalence study of nabumetone-comments on the research work of Patel et al. (2008).
    Srinivas NR
    Biomed Chromatogr; 2009 Jun; 23(6):674-5. PubMed ID: 19277989
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone.
    Matsumoto K; Nemoto E; Hasegawa T; Akimoto M; Sugibayashi K
    Biol Pharm Bull; 2011; 34(5):734-9. PubMed ID: 21532165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of nabumetone and its principal metabolite in medicines and human urine by time-resolved fluorescence.
    Murillo Pulgarín JA; Alañón Molina A; Martínez Ferreras F
    Analyst; 2012 Nov; 137(21):5144-52. PubMed ID: 22977877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver insufficiency as a factor modifying the pharmacokinetic characteristic of the preparation nabumetone.
    Maleev A; Vlahov V; Gruev I; Dierdorf D; Kostova N; Bacracheva N
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):425-9. PubMed ID: 3759278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid
    Matsumoto K; Hasegawa T; Ohara K; Kamei T; Koyanagi J; Akimoto M
    Xenobiotica; 2021 Feb; 51(2):155-166. PubMed ID: 33146575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of nabumetone in human plasma by HPLC. Application to single dose pharmacokinetic studies.
    Kobylińska K; Barlińska M; Kobylińska M
    J Pharm Biomed Anal; 2003 Jun; 32(2):323-8. PubMed ID: 12763542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [6-methoxy-2-naphthylacetic acid level in plasma, synovial fluid and adjacent tissue in patients with rheumatoid arthritis or gonarthroses after a 4-day therapy with nabumetone (Arthaxan)].
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Fedder M
    Z Rheumatol; 1991; 50(2):103-8. PubMed ID: 1872041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplex optimization of the variables affecting the micelle-stabilized room temperature phosphorescence of 6-methoxy-2-naphthylacetic acid and its kinetic determination in human urine.
    Pulgarín JA; Molina AA; Pardo MT
    Anal Biochem; 2005 Apr; 339(1):157-64. PubMed ID: 15766723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.